Skip to content

GLP-1 dose schedule: labeled adult injection checkpoints

Map the earliest labeled discussion dates for selected adult injection regimens. Dates help organize a prescriber conversation; they are not a personalized prescription or an automatic instruction to increase.

Last editorially updated: · By Jeff Schaeffer

Not medical advice. Talk to your prescriber and pharmacist. Confirm your prescribed dose, product, concentration, device, and instructions before using any calculation. This website cannot choose or change your treatment.

Map labeled adult injection checkpoints

Later rows are conditional discussion dates, not automatic instructions to increase. This tool excludes oral products, children, and individualized restart plans.

Earliest discussion dates if the preceding step is completed
WeekDateLabel context

Choose a start date to see checkpoints.

How this is calculated: every formula is written out on this page, the sources are listed at the bottom, and our editorial policy explains how we check and correct numbers.

Comparing GLP-1 program costs?

Use your actual provider quote to estimate the full cost with our cost calculator. You can also review pricing and eligibility directly with a telehealth provider.

SkinnyRxOral and injectable GLP-1 options, with financing.See SkinnyRx options →

Disclosure: GLP1 Math may earn a commission if you sign up through these links. It costs you nothing extra and does not change what the calculators show. A provider listing is not a medical recommendation.

Understand the scope before choosing a date

This tool covers selected adult weekly injection regimens for Wegovy, Ozempic, Zepbound, and Mounjaro. It does not cover oral products, pediatric schedules, every approved indication, compounded treatment plans, or restarting after an interruption. Those boundaries matter because a medicine name may now appear on several presentations with different instructions. Choose the exact product and read the scope beside it. If your prescription falls outside that scope, ask your clinician for a written plan rather than adapting the calendar yourself.

A label describes recommended starting steps and conditions for later changes. It does not say every patient must reach the largest dose on the earliest possible date. The calendar therefore calls later entries checkpoints and marks conditional increases explicitly. Your prescriber may keep a dose unchanged, delay an increase, choose a permitted maintenance option, or change the plan. The tool cannot infer any of those decisions from a start date. Its useful role is to show the dates implied by the selected label sequence so questions can be discussed in advance.

The calendar math is straightforward

The first injection date is week one. A four-week period contains 28 days, so the start of week five is the start date plus 28 days, week nine is plus 56 days, and week thirteen is plus 84 days. The tool adds calendar days without converting the displayed date through a different time zone. A date field is required; no assumed first injection is inserted. If you clear the date, the output clears instead of leaving an old schedule on screen.

For a worked date example, a hypothetical Monday start followed by four weekly injections has injections on days zero, seven, fourteen, and twenty-one. The next four-week block starts on day twenty-eight, not on the date of the fourth injection. Counting injections and counting completed weeks are related but different operations. Writing down both can prevent a one-week shift. This arithmetic still does not authorize a change at day twenty-eight; the relevant product label and prescriber plan supply the clinical conditions.

Wegovy injection requires indication-specific context

The current Wegovy injection label begins with 0.25 mg weekly for weeks one through four, followed by 0.5 mg for weeks five through eight, 1 mg for weeks nine through twelve, and 1.7 mg for weeks thirteen through sixteen. It allows consideration of delaying escalation when a step is not tolerated. From week seventeen onward, maintenance depends on the indication and patient context. The tool's selection is explicitly adult weight management, not every Wegovy use.

For adult weight reduction, the current label lists 1.7 mg or the recommended 2.4 mg weekly maintenance amount. It also permits an increase to 7.2 mg for adults who have tolerated 2.4 mg for at least four weeks and for whom additional weight reduction is clinically indicated. This is a conditional option, not a required next step or a target for every person. The table marks the earliest discussion point and links the label. Older statements that 2.4 mg is always the maximum are not carried forward here.

Ozempic injection is not an identical calendar

For adult glycemic control, the Ozempic injection label begins with 0.25 mg weekly for four weeks and then 0.5 mg. If additional glycemic control is needed after at least four weeks on 0.5 mg, the amount may increase to 1 mg; after at least four weeks on 1 mg, it may increase to 2 mg if additional control is needed. The later rows are conditional. The calendar does not decide that your glucose control requires them.

Ozempic also has indication-specific maintenance instructions, including the current label's section for adults with type 2 diabetes and chronic kidney disease. That is why the selector identifies the glycemic-control scope instead of presenting one sequence as the answer to every prescription. Semaglutide products share an ingredient but do not share every instruction. Read the Ozempic and Wegovy comparison for a structured way to discuss those differences without inventing a switching plan.

Tirzepatide checkpoints differ by product purpose

Zepbound's labeled initiation is 2.5 mg weekly for four weeks, followed by 5 mg weekly. Later increases may occur in 2.5 mg increments after at least four weeks at the current amount. For adult weight management, maintenance options are 5, 10, or 15 mg. Intermediate amounts in an escalation sequence should not be mistaken for a requirement to keep increasing. Other indications have their own label details. The tool names its chosen scope so a calendar does not conceal those distinctions.

Mounjaro's current label starts at 2.5 mg weekly and describes 2.5 mg increases after at least four weeks when additional glycemic control is needed. Its adult maximum is 15 mg; pediatric maximums and device recommendations differ. The displayed adult checkpoints therefore use conditional wording rather than claiming the same mandatory sequence applies to every age and indication. Check the current label and your prescription if an older instruction sheet presents a different sequence. The calendar cannot resolve a discrepancy in medical directions.

Missed doses do not simply reset the calendar

The four brand labels use different rules. Ozempic injection gives a five-day missed-dose window. Zepbound and Mounjaro give a four-day, 96-hour window and a minimum 72-hour interval when changing the weekly day. Wegovy injection compares the next scheduled dose with a two-day interval and has separate instructions after two or more consecutive missed injections. Those are product instructions, not arithmetic derived from a half-life or a dose-escalation table. Splitting semaglutide into twice-weekly injections is a separate regimen question.

If you miss an injection, do not slide every later row by a week and assume the result is a new prescription. Use the missed-dose label guide and contact the prescriber when the situation falls outside the stated rule. In particular, restarting after a longer gap can require a different plan. The site intentionally has no restart-dose calculator. A start date and a prior dose do not provide enough information to safely generate one.

Prepare the next conversation before the checkpoint

Keep a simple record of the exact product, amount prescribed, actual administration dates, and any concerns your clinician has asked you to monitor. If an upcoming increase has not been confirmed, ask before the refill rather than interpreting a calendar entry as approval. Tell the pharmacy if a new prescription will change presentation or concentration so device training and written instructions can be reconciled. A unit marking from the previous vial may no longer represent the same medicine amount.

For vial measurements, use the units converter only after the prescribed mg and concentration have been confirmed. U-100 markings express volume, not the treatment step. Check storage and beyond-use instructions separately: the fact that a calendar says a dose is due does not establish that a previously opened or temperature-exposed container is usable. Our storage guide shows what details to have ready when calling the pharmacist.

Know when a calendar is the wrong tool

A suspected dosing error, an uncertain injection, significant symptoms, or a confusing prescription requires professional help. The site cannot determine whether to repeat a possibly incomplete injection, hold treatment, or manage an adverse reaction. Contact your prescriber or pharmacist promptly about those issues; use emergency services for a medical emergency. A schedule can organize dates after the clinical decision is made, but it must never substitute for that decision. Print or save the label and written plan alongside any calendar you use.

Frequently asked questions

Does every row mean I should increase?

No. Later rows show the earliest checkpoint if preceding requirements are met. Several increases depend on response, tolerability, indication, or glycemic control. Follow the prescriber plan, even when it differs from the earliest dates shown.

Why is Wegovy 7.2 mg mentioned?

The current label permits this conditional adult weight-reduction option after at least four weeks tolerating 2.4 mg when additional reduction is clinically indicated. It is not a universal maintenance target, and the tool does not recommend it for you.

Does this work for tablets?

No. The calendar is limited to the weekly injection scopes named in the selector. Oral semaglutide products have separate administration, escalation, and missed-dose instructions. A brand name alone does not establish which schedule applies.

Can I restart using my original calendar?

Do not assume that. The product, number of missed doses, previous treatment, and current circumstances may require a new prescriber plan. This tool deliberately does not calculate restart amounts or automatically shift a schedule after missed injections.

How is week five calculated?

It is the first date plus 28 calendar days. The fourth weekly injection would normally be 21 days after the first, which is not yet the start of week five. The distinction prevents counting an escalation checkpoint one week early.

Can a compounded vial follow these rows?

Do not automatically transfer a brand schedule to a compounded prescription. Ask the dispensing pharmacy and prescriber for written product-specific directions. The calendar neither validates a compounded formulation nor supplies its missed-dose or storage instructions.

Sources

Related reading